ASH Annual Meeting 2025
Meet with our Safety & Risk Management and Evidence Development Teams
Our evidence development solutions provide expert-driven real-world evidence tailored to specialty patient populations to uncover more valuable insights, maximize commercial positioning, and optimize regulatory approval for the long-term value of your therapy. Leveraging real-world data and the latest biopharma technology platforms and software, we create solutions that are innovative as well as grounded in real-world patient experience, from modernized study design and execution to late-stage research.
Meanwhile, our safety and risk management team creates authoritative, trusted, and reliable strategies to inform and educate providers, patients, and regulators about the benefit/risk profile of specialty therapies. With REMS and PV services curated over decades of leadership, we ensure comprehensive, tailored drug safety and global risk management solutions that are sophisticated, tech-enabled, and regulatory compliant.
At UBC, we connect specialty therapies to the patients who need them most by delivering modern, customized solutions in access, safety, and evidence generation. Meet our team to learn how our consultative approach and deep experience can benefit your product across its lifecycle.
Meet With Us There
Learn More About UBC
We are dedicated to uniting evidence and access for biopharma. Fill out the form to get in touch with our team and learn more.
Other Events
World Patient Safety Congress Americas 2026
World Patient Safety Congress Europe 2026
14th Annual Outsourcing in Clinical Trials Southern California 2026
Meet With Us There
Thank You for Connecting with UBC
.
What You Can Expect Next
.
- Leverage automation to move fast
- Always give customers a human to chat to
- Automate customer support and close leads faster
Get Ready to Change Your Business
.
Service Request
Bekki Bracken Brown
President & Chief Executive Officer
Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.
With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.